Merck Emend Medicare National Coverage Decision Expected By April 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS is accepting public comment on whether aprepitant is a “full replacement” for other anti-emetic treatments in response to an “internally generated” coverage determination request.